Marta Davidson

925 total citations
20 papers, 628 citations indexed

About

Marta Davidson is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Marta Davidson has authored 20 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 9 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in Marta Davidson's work include Acute Myeloid Leukemia Research (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Marta Davidson is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Marta Davidson collaborates with scholars based in Canada, United States and Australia. Marta Davidson's co-authors include Grant W. Brown, Florence Hediger, Susan M. Gasser, Nevan J. Krogan, Shigeki Nagai, Monika Tsai-Pflugfelder, Karine Dubrana, Tania Michelle Roberts, Elisa Varela and David Cawthorpe and has published in prestigious journals such as Science, The EMBO Journal and Blood.

In The Last Decade

Marta Davidson

17 papers receiving 627 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marta Davidson Canada 7 559 65 62 59 46 20 628
Erwan Delbarre Norway 16 880 1.6× 35 0.5× 90 1.5× 68 1.2× 87 1.9× 22 997
Ariana Jacome Spain 8 284 0.5× 41 0.6× 87 1.4× 91 1.5× 32 0.7× 10 325
Andrea Harničarová Czechia 10 520 0.9× 44 0.7× 21 0.3× 65 1.1× 59 1.3× 11 601
Lynn Lehmann United States 8 317 0.6× 44 0.7× 76 1.2× 47 0.8× 29 0.6× 9 406
Kohsuke Kato Japan 11 413 0.7× 65 1.0× 28 0.5× 49 0.8× 40 0.9× 29 501
Henry Pratt United States 12 419 0.7× 39 0.6× 67 1.1× 54 0.9× 34 0.7× 24 532
Christelle de Renty United States 12 355 0.6× 119 1.8× 84 1.4× 31 0.5× 52 1.1× 15 415
Yusuke Tarumoto Japan 10 371 0.7× 50 0.8× 19 0.3× 20 0.3× 64 1.4× 32 468
Takeya Nakagawa Japan 12 710 1.3× 66 1.0× 46 0.7× 97 1.6× 61 1.3× 22 790
Wai Shan Yuen Australia 11 381 0.7× 20 0.3× 52 0.8× 51 0.9× 16 0.3× 16 570

Countries citing papers authored by Marta Davidson

Since Specialization
Citations

This map shows the geographic impact of Marta Davidson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Davidson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Davidson more than expected).

Fields of papers citing papers by Marta Davidson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Davidson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Davidson. The network helps show where Marta Davidson may publish in the future.

Co-authorship network of co-authors of Marta Davidson

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Davidson. A scholar is included among the top collaborators of Marta Davidson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Davidson. Marta Davidson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Richard‐Carpentier, Guillaume, Séverine Cathelin, Lisa Wang, et al.. (2025). Enasidenib plus venetoclax in patients with IDH2-mutated relapsed or refractory acute myeloid leukaemia or myelodysplastic syndrome (ENAVEN-AML): a multicentre, single-arm, phase 1b/2 trial. The Lancet Haematology. 12(11). e887–e897.
2.
Zhou, Qianghua, Marta Davidson, Mark D. Minden, et al.. (2024). A real-world analysis of clinical outcomes in AML with myelodysplasia-related changes: a comparison of ICC and WHO-HAEM5 criteria. Blood Advances. 8(7). 1760–1771. 6 indexed citations
3.
Davidson, Marta, James A. Kennedy, José‐Mario Capo‐Chichi, et al.. (2024). Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN. Blood Advances. 8(5). 1281–1294. 5 indexed citations
4.
Davidson, Marta, Steven M. Chan, Hassan Sibai, et al.. (2024). FLAG-IDA Plus Venetoclax in High-Risk Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia: The Princess Margaret Cancer Center Experience. Blood. 144(Supplement 1). 4273–4273.
5.
Atenafu, Eshetu G., Vikas Gupta, Dawn Maze, et al.. (2024). Outcomes and adverse events in older acute lymphoblastic Leukemia patients treated with a pediatric-inspired protocol with Pegylated or native Asparaginase. Hematology. 29(1). 2329027–2329027. 1 indexed citations
6.
Claudio, Jaime O., Andrea Arruda, Hubert Tsui, et al.. (2023). P1040: FACTORS ASSOCIATED WITH THROMBOSIS IN MYELOFIBROSIS. HemaSphere. 7(S3). e91985c2–e91985c2. 1 indexed citations
7.
Richard‐Carpentier, Guillaume, Séverine Cathelin, Marta Davidson, et al.. (2023). Final Results of the Phase Ib/II Study Evaluating Enasidenib in Combination with Venetoclax in Patients with IDH2-Mutated Relapsed/Refractory Myeloid Malignancies. Blood. 142(Supplement 1). 159–159. 10 indexed citations
8.
Davidson, Marta, et al.. (2022). Iron deficiency, anemia and association with refugee camp exposure among recently resettled refugees: A Canadian retrospective cohort study. PLoS ONE. 17(12). e0278838–e0278838. 2 indexed citations
9.
Davidson, Marta, et al.. (2022). Generalizability of landmark clinical trials in diffuse large B cell lymphoma to real-world patients: a single-center retrospective cohort study. Leukemia & lymphoma. 63(12). 2996–2999. 3 indexed citations
10.
Atenafu, Eshetu G., Steven M. Chan, Marta Davidson, et al.. (2022). Clinical Outcomes in De Novo Versus Secondary NPM1-Mutated AML. Blood. 140(Supplement 1). 8952–8953. 1 indexed citations
11.
Atenafu, Eshetu G., Theodore A. Kennedy, Marta Davidson, et al.. (2022). Comparison of Clinical Outcomes between Transplant and Non-Transplant Therapies in Myelofibrosis Following Failure of First-Line JAK-Inhibitor. Blood. 140(Supplement 1). 9724–9725. 1 indexed citations
12.
Davidson, Marta & Vikas Gupta. (2021). Application of Stem Cell Therapy in Myelofibrosis. Hematology/Oncology Clinics of North America. 35(2). 391–407. 5 indexed citations
13.
14.
Davidson, Marta, Douglas A. Stewart, Peter Duggan, Andrew Daly, & Mona Shafey. (2017). Phase I/II Study of Infusional Gemcitabine and High-Dose Melphalan Conditioning Prior to Autologous Stem Cell Transplantation for Patients with Relapsed/Refractory Lymphoma: Interim Safety Analysis. Blood. 130. 4534–4534. 1 indexed citations
15.
Cawthorpe, David & Marta Davidson. (2015). Temporal Comorbidity of Mental Disorder and Ulcerative Colitis. The Permanente Journal. 19(1). 52–57. 28 indexed citations
16.
Tittel-Elmer, Mireille, Armelle Lengronne, Marta Davidson, et al.. (2012). Cohesin Association to Replication Sites Depends on Rad50 and Promotes Fork Restart. Molecular Cell. 48(1). 98–108. 100 indexed citations
17.
Davidson, Marta, Yuki Katou, Andrea Keszthelyi, et al.. (2012). Endogenous DNA replication stress results in expansion of dNTP pools and a mutator phenotype. The EMBO Journal. 31(4). 895–907. 83 indexed citations
18.
Davidson, Marta & Grant W. Brown. (2009). Dissecting the DNA damage response using functional genomics approaches in S. cerevisiae. DNA repair. 8(9). 1110–1117. 3 indexed citations
19.
Davidson, Marta & Grant W. Brown. (2008). The N- and C-termini of Elg1 contribute to the maintenance of genome stability. DNA repair. 7(8). 1221–1232. 16 indexed citations
20.
Nagai, Shigeki, Karine Dubrana, Monika Tsai-Pflugfelder, et al.. (2008). Functional Targeting of DNA Damage to a Nuclear Pore-Associated SUMO-Dependent Ubiquitin Ligase. Science. 322(5901). 597–602. 362 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erwan Delbarre Breakdown of academic impact, for papers by Ariana Jacome Breakdown of academic impact, for papers by Andrea Harničarová Breakdown of academic impact, for papers by Lynn Lehmann Breakdown of academic impact, for papers by Kohsuke Kato Breakdown of academic impact, for papers by Henry Pratt Breakdown of academic impact, for papers by Christelle de Renty Breakdown of academic impact, for papers by Yusuke Tarumoto Breakdown of academic impact, for papers by Takeya Nakagawa Breakdown of academic impact, for papers by Wai Shan Yuen
Rankless by CCL
2026